Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings Inc    ZBH

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
05/22/2017 05/23/2017 05/24/2017 05/25/2017 05/26/2017 Date
117.79(c) 117.81(c) 119.1(c) 119.3(c) 119.23 Last
1 016 001 1 257 182 1 165 057 631 436 146 223 Volume
+0.10% +0.02% +1.09% +0.17% -0.06% Change
More quotes
Financials ($)
Sales 2017 7 866 M
EBIT 2017 2 490 M
Net income 2017 1 207 M
Debt 2017 9 294 M
Yield 2017 0,79%
Sales 2018 8 117 M
EBIT 2018 2 628 M
Net income 2018 1 531 M
Debt 2018 8 109 M
Yield 2018 0,89%
P/E ratio 2017 22,48
P/E ratio 2018 17,49
EV / Sales2017 4,24x
EV / Sales2018 3,96x
Capitalization 24 056 M
More Financials
Company
Zimmer Biomet Holdings, Inc. designs, manufactures and markets orthopaedic reconstructive products, sports medicine, extremities and trauma products; craniomaxillofacial and thoracic products; dental implants; and related surgical products.The company operates through three geographical segments:... 
More about the company
Surperformance© ratings of Zimmer Biomet Holdings Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on ZIMMER BIOMET HOLDINGS INC
05/23 ZIMMER BIOMET : Bone Growth Stimulating Equipment Market 2017 - DJO, IGEA, Elizu..
05/18 ZIMMER BIOMET : Named Top Workplace on Forbes' "America's Best Large Employers o..
05/18 ZIMMER BIOMET : licenses Intellectual Property from Bonutti Research Inc.
05/17 ZIMMER BIOMET HOLDINGS, INC. (NYSE : ZBH) Files An 8-K Submission of Matters to ..
05/17 ZIMMER BIOMET HOLDINGS, INC. : Submission of Matters to a Vote of Security Holde..
05/09 ZIMMER BIOMET : May 9, 2017 Zimmer Biomet Named Top Workplace on Forbes' "Americ..
05/09 ZIMMER BIOMET : Management's Discussion and Analysis of Financial Condition and ..
05/09 INSIDER TRADING ACTIVITY ZIMMER BIOM : ZBH) – VP Sold 6,200 shares of Stoc..
05/08 ZIMMER BIOMET : May 8, 2017 Zimmer Biomet Holdings to Present at the Bank of Ame..
04/27 ZIMMER BIOMET HOLDINGS, INC. (NYSE : ZBH) Files An 8-K Results of Operations and..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
05/16 Earnings drag on European shares, though Vodafone lifts telcos
05/09 French outbound M&A driven to decade high by big deals
05/06DJProfits Jump, Spending Lags -- WSJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
06:32aZimmer Biomet Holdings Inc $ZBH Stake Held by MUFG Americas Holdings Corp  
06:28aZimmer Biomet Holdings Inc $ZBH Stake Held by Meridian Investment Counsel Inc.. 
06:28aZimmer Biomet Holdings Inc $ZBH Stake Lowered by Hourglass Capital LLC  
05/24Xact Kapitalforvaltning AB Purchases 1,364 Shares of Zimmer Biomet Holdings I.. 
05/24Comerica Bank Reduces Position in Zimmer Biomet Holdings Inc $ZBH  
More tweets
Qtime:29
News from SeekingAlpha
05/25 Tracking Larry Robbins's Glenview Capital Management Portfolio - Q1 2017 Upda..
05/16 Premarket analyst action - healthcare
04/27 Zimmer Biomet Holdings' (ZBH) CEO David Dvorak on Q1 2017 Results - Earnings ..
04/27 HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am
04/27 PREMARKET LOSERS AS OF 9 : 05 am
Advertisement
Chart ZIMMER BIOMET HOLDINGS INC
Duration : Period :
Zimmer Biomet Holdings Inc Technical Analysis Chart | ZBH | US98956P1021 | 4-Traders
Full-screen chart
Technical analysis trends ZIMMER BIOMET HOL...
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 131 $
Spread / Average Target 9,9%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David C. Dvorak President, Chief Executive Officer & Director
Larry C. Glasscock Non-Executive Chairman
Adrian Furey Senior VP-Global Operations & Logistics
Daniel P. Florin Chief Financial Officer & Senior Vice President
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS..15.60%24 056
MEDTRONIC PLC18.91%117 149
BAXTER INTERNATIONAL I..31.57%32 153
C R BARD INC37.36%22 347
HOYA CORPORATION11.85%19 252
TERUMO CORP2.43%15 097
More Results